Ignite Creation Date:
2024-05-06 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05199688
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2021-12-03
Brief Title:
A Study To Evaluate Pharmacokinetics Efficacy Safety Tolerability And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder NMOSD
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-03
First Submit QC Date:
January 5 2022
Study First Post Date:
2022-01-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL